EU Warns Of Anaphylaxis With MS Drug ‘Months Or Years’ After Start Of Treatment
A direct communication to health care professionals says that the initial symptoms of anaphylaxis with glatiramer acetate might overlap with those of post-injection reactions and could lead to a delay in identifying an anaphylactic reaction.
